Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Colorectal Cancer Predicted by Merging Risk Factors

By LabMedica International staff writers
Posted on 14 Mar 2017
A team of Spanish cancer researchers has devised a method for predicting risk of developing colorectal cancer (CRC) that combines life style choices, family background, and genetic data.

Investigators at IDIBELL-Bellvitge Biomedical Research Institute set out to elaborate a model to stratify the risk of CRC by merging environmental information and single nucleotide polymorphisms (SNPs) data. More...
To achieve this end, they conducted a case-control study that included 1336 CRC cases and 2744 controls. Subjects were interviewed on lifestyle factors, family, and medical history. In addition, 21 CRC susceptibility SNPs were genotyped.

Results revealed that the environmental risk model, which included alcohol consumption, obesity, physical activity, red meat and vegetable consumption, and nonsteroidal anti-inflammatory drug use, contributed to CRC with an average OR (odds ratio) factor of 1.36. Family history of CRC contributed an OR of 2.25, and each additional SNP contributed an OR of 1.07. The risk of subjects with more than 25 risk alleles (fifth quintile) was 82% higher than subjects with less than 19 alleles (first quintile). Thus, environmental factors had more weight than the genetic score, which should be considered to encourage patients to achieve a healthier lifestyle.

The investigators did stress that this study only included 21 risk SNPs, while more than 60 have already been identified. More studies will be needed to determine the generalizability, usefulness of information, and the cost-effectiveness of applying individual genotyping in a CRC screening program.

"A risk model is a mathematical tool that allows us to predict who is most likely to suffer from a particular disease, in this case colon cancer," said senior author Dr. Victor Moreno, professor of medicine and health sciences head at IDIBELL-Bellvitge Biomedical Research Institute. "Today, screening for colon cancer in patients with no family history is based solely on age. If we include information about lifestyle and genetics, we could classify the population into groups of greater or lesser risk, which would allow us to offer a more personalized follow-up."

The study was published in the February 24, 2017, online edition of the journal Scientific Reports.


Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Clinical Chemistry System
P780
Hemodynamic System Monitor
OptoMonitor
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Residual leukemia cells may predict long-term survival in acute myeloid leukemia (Photo courtesy of Shutterstock)

MRD Tests Could Predict Survival in Leukemia Patients

Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read more

Immunology

view channel
Image: The simple blood marker can predict which lymphoma patients will benefit most from CAR T-cell therapy (Photo courtesy of Shutterstock)

Routine Blood Test Can Predict Who Benefits Most from CAR T-Cell Therapy

CAR T-cell therapy has transformed treatment for patients with relapsed or treatment-resistant non-Hodgkin lymphoma, but many patients eventually relapse despite an initial response. Clinicians currently... Read more

Pathology

view channel
Image: Determining EG spiked into medicinal syrups: Zoomed-in images of the pads on the strips are shown. The red boxes show where the blue color on the pad could be seen when visually observed (Arman, B.Y., Legge, I., Walsby-Tickle, J. et al. https://doi.org/10.1038/s41598-025-26670-1)

Rapid Low-Cost Tests Can Prevent Child Deaths from Contaminated Medicinal Syrups

Medicinal syrups contaminated with toxic chemicals have caused the deaths of hundreds of children worldwide, exposing a critical gap in how these products are tested before reaching patients.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.